Examinando por Autor "Espíritu Hinostroza, Elí Eleizer"

Mostrando 1 - 1 de 1

Acceso abierto
Identificación de problemas relacionados a los medicamentos en tratamientos farmacológicos de pacientes COVID, hospitalizados en Clínica Internacional sede Lima, abril–agosto, 2020
(Universidad Privada Norbert Wiener, 2021-08-05) Espíritu Hinostroza, Elí Eleizer; Gómez Ochante, Drisly Disan; Torres Veliz, Ernesto Raúl
The objective of this study was to identify Drug-Related Problems (DRPs) in the pharmacological treatments of hospitalized COVID patients at Clínica Internacional, Lima branch (April – August 2020). Methodology: The study was descriptive, analytical, and comparative. The research approach was deductive quantitative, the investigation was basic, and the design was non-experimental. Stratified random probabilistic sampling was performed, with each month representing a stratum. The sample consisted of 289 Pharmacotherapeutic Follow-up (PFU) forms for patients with COVID treatment, which were used for the evaluation of DRPs. Results: 95.2% of the PFU reports for hospitalized patients corresponded to potential DRPs. Regarding age and gender, the age range between 19 and 49 years presented DRPs at 31.8%, and the male gender at 70.2%. Furthermore, concerning DRP subtypes, 95.5% corresponded to safety DRPs. Regarding the therapeutic groups causing DRPs, the most frequent were antibiotics, which generated 91 DRPs in patients, representing 15.7% of the studied sample. Conclusions: The percentage of DRPs was identified through the PFU forms, with potential DRPs being the most prevalent. The age range that presented the most DRPs was 19–49 years, and the male gender presented a greater number of DRPs. The safety subtype had the highest percentage among the other subtypes. Additionally, the main therapeutic groups that cause DRPs are antibiotics, followed by antipsychotics.